Nominate a 2024 STAT Wunderkind
Nominate a 2024 STAT Wunderkind STAT Wunderkinds is a chance to celebrate early-career researchers who are not yet independent scientists or program
Related Articles
Several hundred NIH employees sign a letter of protest to the agency’s director
Several hundred NIH employees signed on to a letter rebuking agency actions since the start of President Trump’s second term
The nightmarish tale of what happened to a child who wasn’t vaccinated
The boy was 6 years old and his parents refused to vaccinate him. He developed tetanus and landed in a hospital, the start of a…
NIH walks back ban on new grants for universities with DEI programs or Israel boycotts
The NIH has rescinded a policy requiring recipients of new grants to certify they do not have unlawful DEI programs or boycotts of Israel.
5 food power players have strong ties to the MAHA movement
Companies like Sweetgreen, Daily Harvest, and Thrive Market have strong ties to MAHA leaders, including Casey and Calley Means.
GOP senators zero in on Medicaid policy in Trump’s tax bill that has little impact on enrollment
Republicans have faced pushback for plans to pay for Trump’s tax cuts by reducing Medicaid funding.
Health secretary RFK Jr. abruptly fires CDC vaccine advisory panel
Health secretary Robert F. Kennedy Jr. has taken the extraordinary step of firing the expert panel that advises the CDC.
Merck’s RSV antibody treatment for infants is approved by FDA
The simplicity of Merck’s monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca’s existing treatment.
Merck’s RSV antibody treatment for infants is approved by FDA
The simplicity of Merck’s monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca’s existing treatment.
National Resilience, startup hoping to reinvent drug manufacturing, to ‘wind down’ many of its facilities
National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said it would “wind down” many of its facilities.
National Resilience, startup hoping to reinvent drug manufacturing, to ‘wind down’ many of its facilities
National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said it would “wind down” many of its facilities.